KIT to help Korean drugs gain U.S. FDA approval
Published: 2013-03-04 06:57:00
Updated: 2013-03-04 06:57:00
The U.S. Food and Drug Administration has recently approved the preclinical data submitted by a local non-clinical contract research organization, which will help Korean drug firms increase their share of the U.S. pharmaceutical market.
The Korea Institute of Toxicology (KIT) has since 2005 of...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
